Inflammatory serum markers predicting spontaneous ureteral stone passage.


Journal

Clinical and experimental nephrology
ISSN: 1437-7799
Titre abrégé: Clin Exp Nephrol
Pays: Japan
ID NLM: 9709923

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 25 09 2019
accepted: 23 10 2019
pubmed: 11 11 2019
medline: 15 12 2020
entrez: 10 11 2019
Statut: ppublish

Résumé

Ureteral stones pose a high economic and medical burden among Emergency Department (ED) admissions. Management strategies vary from expectant therapy to surgical interventions. However, predictors of spontaneous ureteral stone passage are still not well understood. We aim to explore the role of neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios in the spontaneous ureteral stone passage (SSP). Chart review was done for 619 patients who presented to our institution's ED with non-febrile renal colic and received a radiological diagnosis of ureteral stone of less than 10 mm. Demographic, clinical, laboratory, and radiological data were collected. The Linear-by-Linear Association test was used to look at the trend among the NLR and PLR quartiles and other demographic variables. Univariate analysis was run for the collected variables. Then, a hierarchal backward multivariate logistic regression was run for each of NLR and PLR variables. To validate the results, bootstrapping was undertaken for each model. NLR between 2.87 and 4.87 had odds ratio (OR) 2.96 (95% CI 1.80-5.49) and an NLR > 4.87 had 3.63 (2.04-6.69) the odds of retained ureteral stone. A PLR between 10.42 and 15.25 and a PLR > 15.25 had 3.28 (1.79-6.19) and 3.84 (2.28-7.12) the odds of failed SSP, respectively. Other significant variables in the two models are diabetes, urine leukocyte esterase > 10 white blood cell/μl, moderate-to-severe hydronephrosis, and stone size. NLR and PLR are inversely associated with SSP of ureteral stones. In adjunct with other indicators, NLR and PLR are inflammatory markers that could be used in the clinical decision of ureteral stone management.

Identifiants

pubmed: 31705331
doi: 10.1007/s10157-019-01807-5
pii: 10.1007/s10157-019-01807-5
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

277-283

Références

J Urol. 2005 Mar;173(3):848-57
pubmed: 15711292
Int J Urol. 1999 Jun;6(6):281-5
pubmed: 10404303
Actas Urol Esp. 2010 Nov;34(10):882-7
pubmed: 21159285
J Endourol. 2010 Jun;24(6):923-30
pubmed: 20482232
Ther Umsch. 2003 Feb;60(2):79-87
pubmed: 12649986
Eur Urol. 2008 Feb;53(2):411-8
pubmed: 17889988
Nephron Clin Pract. 2010;116(3):c159-71
pubmed: 20606476
Eur Urol. 2016 Mar;69(3):475-82
pubmed: 26344917
World J Surg. 2011 Apr;35(4):868-72
pubmed: 21312035
J Urol. 2002 Apr;167(4):1621-9
pubmed: 11912376
Adv Chronic Kidney Dis. 2009 Jan;16(1):5-10
pubmed: 19095200
AJR Am J Roentgenol. 2002 Jan;178(1):101-3
pubmed: 11756098
Korean J Urol. 2015 Jun;56(6):455-60
pubmed: 26078843
Urolithiasis. 2013 Jun;41(3):235-9
pubmed: 23468212
Rev Urol. 2005 Spring;7(2):67-74
pubmed: 16985812
BJU Int. 2012 Oct;110(8 Pt B):E339-45
pubmed: 22372435
BMC Res Notes. 2017 Jan 3;10(1):12
pubmed: 28057051
Clin Radiol. 2013 Sep;68(9):e484-90
pubmed: 23684519
Korean J Urol. 2013 Sep;54(9):615-8
pubmed: 24044096
Actas Urol Esp. 2009 Oct;33(9):1005-10
pubmed: 19925762
Ulus Travma Acil Cerrahi Derg. 2014 Jan;20(1):19-22
pubmed: 24639310
Scand J Urol. 2018 Apr;52(2):94-100
pubmed: 29385947
Eur J Cancer. 2011 Nov;47(17):2633-41
pubmed: 21724383
Yonsei Med J. 2017 Sep;58(5):988-993
pubmed: 28792143
J Urol. 2015 Oct;194(4):1009-13
pubmed: 25963189
J Emerg Trauma Shock. 2011 Jan;4(1):70-6
pubmed: 21633572
Eur Urol. 2017 Nov;72(5):772-786
pubmed: 28456350
Clin Chim Acta. 2018 Aug;483:48-56
pubmed: 29678631

Auteurs

Nassib Abou Heidar (N)

Division of Urology, Department of Surgery, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.

Muhieddine Labban (M)

Division of Urology, Department of Surgery, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.

Gerges Bustros (G)

Division of Urology, Department of Surgery, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.

Rami Nasr (R)

Division of Urology, Department of Surgery, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon. rn05@aub.edu.lb.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH